Studsvik AB (SVIK)
Stockholm Exchange · Sweden · prices in SEK · close of 20 Oct 2026
Key indicators
| Last close | SEK 212.00 |
|---|---|
| 52-week range | 190.00 – 371.00 |
| Return, 1 month / 3 months | −7.2% / +3.9% |
| Return, 1 year / 3 years | −16.2% / +106.8% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 55.8% |
| Worst drawdown (1 year) | -46.7% |
| Average daily value traded | 6.56M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Studsvik AB is a Swedish nuclear technology company based in Nykoping. It provides engineering and technical services to the nuclear power industry, including management of radioactive waste, dismantling of nuclear facilities and radiation protection. The company also offers fuel-related services and software used in nuclear operations. Its customers are mainly utilities, research organisations and industrial firms that work with nuclear materials, and it operates across Europe and other markets.
Studsvik AB trades under the code SVIK on the Stockholm Exchange in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Studsvik AB (SVIK) trades on the Stockholm Exchange in Sweden. It last closed at SEK 212.00 on 20 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 553 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 16.2% and over the last three months it rose 3.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 27 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -17.6% | ||
| From 52-week high | -41.8% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 3.9% | ||
| 6-month return | -28.0% | ||
| 12-month return, skipping the last month | -9.7% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 55.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.7% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 6.56M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +0.5% |
|---|---|
| 1 month | −7.2% |
| 3 months | +3.9% |
| 6 months | −28.0% |
| 1 year | −16.2% |
| 3 years | +106.8% |
| 5 years | +152.7% |
Signals
| 50-day / 200-day average | 219.36 / 257.25 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.88 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Apr 2025 | SEK 2.0000 |
| 26 Apr 2024 | SEK 2.0000 |
| 25 Apr 2023 | SEK 2.0000 |
| 27 Apr 2022 | SEK 2.0000 |
| 24 Jun 2021 | SEK 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.